RYALTRIS (OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE)
Live / Registered — Registered (as of 13 Feb 2024)
What this means for you
Registered since 13 Feb 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97523311
- Registration number
- 7306495
- Mark type
- Design + words
- Filed
- 07 Jul 2022
- Published for opposition
- 22 Aug 2023
- Registered
- 13 Feb 2024
- Attorney of record
- Maxim A. Voltchenko
Goods and services
- Class 005 — Pharmaceuticals: Antihistamine, nasal steroid, nasal spray product for treatment of respiratory disorder; Antihistamine delivery device sold filled; nasal steroid delivery device sold filled
Owner
- Glenmark Specialty S.A., La Chaux-De-Fonds, CH
- Glenmark Specialty S.A., Neuchâtel, CH
- Glenmark Specialty S.A., Neuchâtel, CH
Prosecution history
- 19 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 May 2025 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 19 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 May 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 May 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 13 Feb 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Feb 2024 — REGISTERED-PRINCIPAL REGISTER
- 09 Jan 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Jan 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Jan 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Dec 2023 — USE AMENDMENT FILED
- 05 Jan 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Dec 2023 — TEAS STATEMENT OF USE RECEIVED
- 17 Oct 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT